Concepts (84)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 8 | 2017 | 76 | 2.810 |
Why?
|
| Income | 3 | 2017 | 78 | 1.600 |
Why?
|
| Astrocytoma | 4 | 2016 | 16 | 1.290 |
Why?
|
| Oligodendroglioma | 3 | 2016 | 4 | 1.180 |
Why?
|
| Insurance Coverage | 2 | 2017 | 15 | 1.110 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 154 | 1.060 |
Why?
|
| Medically Uninsured | 2 | 2017 | 12 | 0.710 |
Why?
|
| Radiation Injuries | 3 | 2017 | 28 | 0.680 |
Why?
|
| Glioma | 3 | 2014 | 19 | 0.670 |
Why?
|
| Gliosarcoma | 2 | 2017 | 2 | 0.670 |
Why?
|
| Mouth Neoplasms | 1 | 2018 | 20 | 0.600 |
Why?
|
| Pharyngeal Neoplasms | 1 | 2017 | 4 | 0.580 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2017 | 16 | 0.570 |
Why?
|
| Cranial Irradiation | 2 | 2014 | 13 | 0.560 |
Why?
|
| Insurance, Health | 1 | 2016 | 20 | 0.540 |
Why?
|
| Combined Modality Therapy | 2 | 2016 | 281 | 0.530 |
Why?
|
| Healthcare Disparities | 1 | 2016 | 74 | 0.510 |
Why?
|
| Young Adult | 7 | 2018 | 1855 | 0.500 |
Why?
|
| Adolescent | 5 | 2018 | 2076 | 0.460 |
Why?
|
| Aged, 80 and over | 6 | 2018 | 4459 | 0.440 |
Why?
|
| Aged | 10 | 2019 | 8501 | 0.430 |
Why?
|
| Radiotherapy, Adjuvant | 3 | 2018 | 49 | 0.420 |
Why?
|
| Kaplan-Meier Estimate | 3 | 2016 | 157 | 0.390 |
Why?
|
| Adult | 8 | 2018 | 7336 | 0.380 |
Why?
|
| Middle Aged | 9 | 2018 | 8403 | 0.380 |
Why?
|
| Male | 13 | 2019 | 13917 | 0.380 |
Why?
|
| Female | 12 | 2019 | 14273 | 0.360 |
Why?
|
| Humans | 15 | 2019 | 25692 | 0.300 |
Why?
|
| Prognosis | 4 | 2019 | 739 | 0.280 |
Why?
|
| Medicaid | 2 | 2017 | 29 | 0.280 |
Why?
|
| Proportional Hazards Models | 2 | 2018 | 332 | 0.270 |
Why?
|
| Medicare | 2 | 2017 | 107 | 0.260 |
Why?
|
| Chemotherapy, Adjuvant | 2 | 2016 | 69 | 0.260 |
Why?
|
| Regression Analysis | 2 | 2016 | 255 | 0.250 |
Why?
|
| Survival Rate | 4 | 2019 | 308 | 0.230 |
Why?
|
| Age Factors | 2 | 2016 | 716 | 0.220 |
Why?
|
| Neural Stem Cells | 2 | 2014 | 12 | 0.210 |
Why?
|
| United States | 3 | 2019 | 1943 | 0.210 |
Why?
|
| Databases, Factual | 2 | 2019 | 329 | 0.160 |
Why?
|
| Melanoma | 1 | 2019 | 52 | 0.150 |
Why?
|
| Paranasal Sinus Neoplasms | 1 | 2019 | 58 | 0.150 |
Why?
|
| Propensity Score | 1 | 2018 | 32 | 0.150 |
Why?
|
| Private Sector | 1 | 2017 | 2 | 0.150 |
Why?
|
| Neoplasm Grading | 2 | 2014 | 40 | 0.140 |
Why?
|
| Pituitary Neoplasms | 1 | 2017 | 16 | 0.140 |
Why?
|
| Social Class | 1 | 2017 | 64 | 0.140 |
Why?
|
| Frail Elderly | 1 | 2017 | 51 | 0.140 |
Why?
|
| Survival Analysis | 1 | 2017 | 246 | 0.140 |
Why?
|
| Paranasal Sinuses | 1 | 2017 | 50 | 0.140 |
Why?
|
| Karnofsky Performance Status | 1 | 2016 | 2 | 0.130 |
Why?
|
| Radiotherapy, Intensity-Modulated | 2 | 2014 | 37 | 0.130 |
Why?
|
| Retrospective Studies | 4 | 2019 | 3220 | 0.130 |
Why?
|
| Multivariate Analysis | 1 | 2016 | 299 | 0.120 |
Why?
|
| Sinusitis | 1 | 2017 | 144 | 0.120 |
Why?
|
| Neoplastic Stem Cells | 1 | 2014 | 6 | 0.120 |
Why?
|
| Standard of Care | 1 | 2014 | 12 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2014 | 32 | 0.110 |
Why?
|
| Parotid Gland | 1 | 2014 | 18 | 0.110 |
Why?
|
| Lymphatic Metastasis | 1 | 2014 | 81 | 0.110 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2014 | 198 | 0.110 |
Why?
|
| Head and Neck Neoplasms | 1 | 2014 | 146 | 0.100 |
Why?
|
| Limbic System | 1 | 2011 | 8 | 0.100 |
Why?
|
| Pluripotent Stem Cells | 1 | 2011 | 6 | 0.090 |
Why?
|
| Hippocampus | 1 | 2011 | 262 | 0.080 |
Why?
|
| Magnetic Resonance Imaging | 4 | 2017 | 1084 | 0.080 |
Why?
|
| Brain | 1 | 2017 | 1560 | 0.080 |
Why?
|
| Nasal Mucosa | 1 | 2019 | 12 | 0.040 |
Why?
|
| Neoplasm Staging | 1 | 2019 | 315 | 0.040 |
Why?
|
| Growth Hormone-Secreting Pituitary Adenoma | 1 | 2017 | 3 | 0.040 |
Why?
|
| Facial Pain | 1 | 2017 | 7 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2017 | 21 | 0.040 |
Why?
|
| Headache | 1 | 2017 | 32 | 0.040 |
Why?
|
| Eosinophilia | 1 | 2017 | 35 | 0.040 |
Why?
|
| Nasal Polyps | 1 | 2017 | 54 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2017 | 341 | 0.030 |
Why?
|
| Chronic Disease | 1 | 2017 | 403 | 0.030 |
Why?
|
| Rhinitis | 1 | 2017 | 131 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2017 | 913 | 0.030 |
Why?
|
| Tumor Burden | 1 | 2011 | 25 | 0.020 |
Why?
|
| Brain Edema | 1 | 2011 | 19 | 0.020 |
Why?
|
| Radiotherapy Dosage | 1 | 2011 | 110 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2011 | 207 | 0.020 |
Why?
|
| Child | 1 | 2014 | 1277 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2014 | 1689 | 0.020 |
Why?
|